Back

Skeletal muscle structural changes in patients with heart failure with reduced ejection fraction: a one-year longitudinal study

18 May 2025 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Inflammation, frailty, and vascular function: exploring prognostic and therapeutic strategies Peripheral Circulation, Metabolism, Skeletal Muscle HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Omar Ziga

Aarhus (Denmark)

5 More presentations in this session

Presentation thumbnail
Exploring the overlap: prevalence and predictors of orthostatic hypotension in heart failure
Doctor P. Bernardes (Setubal, PT)
Abstract Slides Video
Presentation thumbnail
Sex differences of inflammatory drivers of muscle wasting in patients with heart failure with reduced ejection fraction
Doctor A. Tinggaard (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Frailty, inflammation, prognosis and thyroid hormones in heart failure: the clinical relevance of the FT3/FT4 ratio
Assistant Professor C. Okoye (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Aerobic exercise training and AAV9-mediated miRNA-205 delivery prevent metabolic and phenotypic skeletal muscle changes induced by heart failure
Mr B. Pelozin (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of finerenone according to frailty in patients with heart failure: a prespecified analysis of the FINEARTS-HF trial
Doctor J. Butt (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Inflammation, frailty, and vascular function: exploring prognostic and therapeutic strategies

The Event

Event poster

Heart Failure 2025

18 May 2025 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Dynapenia, sarcopenia, hydric alterations and body composition according to the type of heart failure
thumbnail
Congress Presentation
Differential effects of heart failure with reduced ejection fraction on locomotor and respiratory muscles
thumbnail
Congress Presentation
Improvement of functional capacity in patients with heart failure and improved ejection fraction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources